Clinical trial
58-Week Open-label Trial of Tavapadon in Parkinson's Disease (TEMPO-4 Trial)
NCT04760769 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 58-Week Open-label Trial of Tavapadon in Parkinson's Disease (TEMPO-4 Trial)
- Lead sponsor
- AbbVie
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 24, 2021
- Completion date
- December 1, 2025
- Enrollment
- 992 (actual)
- Sites
- 140
Conditions
As the registry lists them; a condition with its own page is linked.